Skip to content
  • Bioequivalence
  • Community
  • Investors

Now providing Mesenchymal cell-based immunomodulation for Covid19-induced hypercytokinemia. Call us to learn more

Somata
Genesis Biopharmaceuticals
  • Covid-19
    • Clinical Trials
    • Products
      • Ventilator
  • Treatments
    • Neurodegenerative Diseases
      • Multiple sclerosis
      • Amyotrophic lateral sclerosis
      • Parkinson’s disease
      • Cerebral palsy
      • Autism
    • Diabetes T2
    • Critical limb ischemia
    • Kidney disorder
    • Stroke
  • Biopharmaceuticals
    • Neutrojen
    • Somajen
    • Stem cells
  • Services
    • Bioequivalence
    • Pharmacokinetics
  • Discoveries
    • Multiple Sclerosis
    • COVID-19

Day: January 11, 2018

Scientists make cells that enable the sense of touch
Stem Cell News

Scientists make cells that enable the sense of touch

Researchers are the first to create sensory interneurons from stem cells Source: University of California – Los Angeles Health Sciences Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research…

by admin
- Jan. 11, 2018
chat_bubble_outline0
Read morearrow_forward
Shocking New Study Shows Half of Cancer Patients are Killed by Chemotherapy, Not Cancer
Articles

Shocking New Study Shows Half of Cancer Patients are Killed by Chemotherapy, Not Cancer

No matter how much doctors push the treatment, chemotherapy might not be the best option in the fight against cancer, as a new study shows up to 50 percent of patients are killed by the…

by admin
- Jan. 11, 2018
chat_bubble_outline0
Read morearrow_forward
https://www.facebook.com/somatagenesis
PO Box 66 Albion ID 83311, USA
International +91 992 149 6595
USA +1 646 583 1660
info@somatagenesis.com
  • Neutrojen
  • Somajen
  • Stem cells
  • Bioequivalence
  • Contact
  • COVID-19
  • Multiple Sclerosis Research
Copyright © 2025 Somata Genesis, Inc. | 416, Burlington Tower, Business Bay, Dubai, United Arab Emirates
  • Facebook
  • LinkedIn
  • Twitter